Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of streptococcus pneumoniae in children living in SAARC countries: A systematic review

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Jaiswal, Nishant ^a   Singh, Meenu ^a   Das, Rashmi Ranjan ^b   Jindal, Ishita ^a   Agarwal, Amit ^a   Thumburu, Kiran Kumar ^a   Kumar, Ajay ^c   Chauhan, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; VANCOMYCIN; ANTIINFECTIVE AGENT; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BANGLADESH; CHILD; COMMUNITY; HOSPITAL; HUMAN; INDIA; NEPAL; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAKISTAN; PNEUMOCOCCAL INFECTION; PREVALENCE; RETROSPECTIVE STUDY; REVIEW; SEROTYPE; SRI LANKA; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; ASIA; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; NEWBORN; PNEUMONIA, PNEUMOCOCCAL; PRESCHOOL CHILD; SEROTYPING; STATISTICS AND NUMERICAL DATA; VACCINATION;

STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ASIA, WESTERN; CHILD; CHILD, PRESCHOOL; CHLORAMPHENICOL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROGROUP; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VACCINATION; VACCINES, CONJUGATE;

EID: 84907537040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108617     Document Type: Review

References (35)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
2. Liu L, Johnson HL, Cousens S, Perin J, Scott S, et al. (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379: 2151-61.
3. World Health Organization (2006) World health statistics 2006. Geneva: World Health Organization. Available: http://www.who.int/whosis/whostat2006.pdf. Accessed: 2014 Aug 1.
4. Child Health Epidemiology Reference Group (CHERG). Underlying causes of child death. Available: http://cherg.org/projects/underlying-causes.html. Accessed: 2014 Aug 1.
5. Giebink GS (2001) The prevention of pneumococcal disease in children. N Engl J Med 345: 1177-1183.
6. GAVI Alliance. Pakistan tackles top child killer - Pneumonia. Available: http:// www.gavialliance.org/library/audio-visual/videos/pakistan-tackles-top-childkiller-pneumonia/. Accessed: 2014 Jan 31.
7. Mastro TD, Ghafoor A, Nomani NK, Ishaq Z, Anwar F, et al. (1991) Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 337: 156-159.
8. Saha SK, Rikitomi N, Biswas D, Watanabe K, Ruhulamin M, et al. (1997) Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995. J Clin Microbiol 35: 785-787.
9. Saha SK, Rikitomi N, Ruhulamin M, Masaki H, Hanif M, et al. (1999) Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains causing childhood infections in Bangladesh, 1993 to 1997. J Clin Microbiol 37: 798-800.
10. Thomas K, IBIS group, INCLEN (1999) Prospective multicentre hospital surviellance of Streptococcus pneumoniae disease in India. The Lancet 353: 1216-1221.
11. Thomas K, IBIS Group, INCLEN. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group. Available: http://www.inclentrust.org/uploadedbyfck/file/publicadon/the%20inclen/Annex%201-IBISI%202final,pdf. Accessed: 2013 Dec 24.
12. Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, et al. (2003) Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol 41: 5582-5587.
13. Brooks WA, Breiman RF, Go swami D, Hossain A, Alam K, et al. (2007) Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 77: 795-801.
14. Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, et al. (2009) Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin Infect Dis 48: S103-113.
15. Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, et al. (2009) Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network. Clin Infect Dis 48: S123 -128.
16. Williams EJ, Thorson S, Maskey M, Mahat S, Hamaluba M, et al. (2009) Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal. Clin Infect Dis 48: SI14-122.
17. Batuwanthudawe R, Karunarathne K, Dassanayake M, de Silva S, Lalitha MK, et al. (2009) Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin Infect Dis 48: SI36 -140.
18. Saha SK, Naheed A, El Arifeen S, Islam M, Al-Emran H, et al. (2009) Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis 48: S75-81.
19. Rij al B, Tandukar S, Adhikari R, Tuladhar NR, Sharma PR, et al. (2010) Antimicrobial susceptibility pattern and serotyping of Streptococcus pneumoniae isolated from Kanti Children Hospital in Nepal. Kathmandu Univ Med J (KUMJ) 8: 164-168.
20. Kelly DF, Thorson S, Maskey M, Mahat S, Shrestha U, et al. (2011) The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal. Int J Infect Dis 15: el7-23.
21. Mancharan A, et al. (2013) Surveillance of Invasive Disease caused by Streptococcus pneumoniae or Haemophilus influenzae or Neisseria meningitidis in Children (<5 years) in India. Abstract presented at the 31st meeting of the European Society for Paediatric Infectious Disease (ESPID). Available: www. asipindia.org/ESPID2013.pdf
22. Shakoor S, Kabir F, Khowaja AR, Qureshi SM, Jehan F, et al. (2014) Pneumococcal Serotypes and Serogroups Causing Invasive Disease in Pakistan, 2005-2013. PLoS ONE 9: e98796.
23. Kumar KLR, Ganaie F, Ashok V (2013) Circulating Serotypes and Trends in Antibiotic Resistance of Invasive Streptococcus Pneumoniae from Children under Five in Bangalore. J Clin Diagn Res 7: 2716-2720.
24. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, et al. (2010) Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 7: el000348.
25. Hausdorff WP, Hoet B, Schuerman L (2010) Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A? BMC Pediatr 10: 4.
26. Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group, et al. (2014) Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med 2: 464-471.
27. Gomez JA, Tirado JC, Navarro Rojas AA, Castrejon Alba MM, Topachevskyi O (2013) Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru. BMC Public Health 13: 1025.
28. Klok RM, Lindkvist RM, Ekelund M, Farkouh RA, Strutton DR (2013) Costeffectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden. Clin Ther 35: 119-134.
29. Earnshaw SR, McDade CL, Zanotti G, Farkouh RA, Strutton D (2012) Costeffectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada. BMC Infect Dis 12: 101.
30. Urueña A, Pippo T, Betelu MS, Virgilio F, Giglio N, et al. (2011) Costeffectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina. Vaccine 29: 4963-4972.
31. Castañeda-Orjuela C, Alvis-Guzmán N, Velandia-González M, De la HozRestrepo F (2012) Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children. Vaccine 30: 1936-1943.
32. Ayieko P, Griffiths UK, Ndiritu M, Moisi J, Mugoya IK, et al. (2013) Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children. PLoS ONE 8: e67324.
33. Kim SY, Lee G, Goldie SJ (2010) Economic evaluation of pneumococcal conjugate vaccination in The Gambia. BMC Infect Dis 10: 260.
34. Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang Y, et al. (2012) Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 56: 1418-1426.
35. Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, et al. (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122: 229-237.